Dr. Sabbagh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
240 W. Thomas Rd,
Ste 301
Phoenix, AZ 85013Phone+1 602-406-8284Fax+1 602-406-5926- Is this information wrong?
Summary
- Dr. Marwan Sabbagh is a neurologist in Phoenix AZ. He received his medical degree from University of Arizona College of Medicine - Tucson and has been in practice 26 years. He specializes in neurodegenerative and is experienced in general neurology, alzheimer's disease, parkinson's disease, and behavioral neurology / neuropsychiatry.
Education & Training
- University of California (San Diego) Medical CenterResidency, Neurology, 1995 - 1997
- Baylor College of MedicineResidency, Neurology, 1992 - 1995
- University of Arizona College of Medicine-PhoenixInternship, Internal Medicine, 1991 - 1992
- University of Arizona College of MedicineClass of 1991
- University of California - BerkeleyB.A., 1987
Certifications & Licensure
- CA State Medical License 1995 - Present
- AZ State Medical License 1994 - 2025
- NV State Medical License 2018 - 2023
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- WestMarc Innovator Award 2015
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Fellow American Academy of Neurology, 2004
- Join now to see all
Clinical Trials
- Thalidomide for Patients With Mild to Moderate Alzheimer's Disease Start of enrollment: 2010 Mar 01
- The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) Start of enrollment: 2014 Jan 08
- Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI) Start of enrollment: 2013 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Conjugal Synucleinopathies: A Clinicopathologic Study.Matthew Halverson, Nan Zhang, Geidy E Serrano, Christine M Belden, Kathy Long, Charles H Adler, Holly A Shill, Erika Driver-Dunckley, Shyamal H Mehta, Alireza Atri, Jo...> ;Movement Disorders. 2024 Apr 10
- Impact of incidental synucleinopathy in mild cognitive impairment due to Alzheimer disease.Michael Malek-Ahmadi, Chase Irwin, Marwan Sabbagh, Jahnavi Shriram> ;Journal of Neuropathology and Experimental Neurology. 2024 Mar 20
- In Reply to Halperin.Lageman, S., Fontanesi, J., Wilson, G., Boling, P., Karis, J., Harris, T., Rogers, C., Bansal, S., Sabbagh, M., Mehta, M.> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Feb 1
- Join now to see all
Journal Articles
- Feasibility Study: Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative DiseasesSerrano GE, Intorcia A, Carew J, Chiarolanza G, Hidalgo JA, Sue LI, Dugger BN, Saxon-LaBelle M, Filon J, Scroggins A, Pullen J, Fornwalt BE, Scott S, Sabbagh MN, Adler..., J Neuropathol Exp Neurol, 1/30/2015
- A phase 3 trial of whole brain and regional ß-amyloid pathology as compared to 18F-florbetaben positron emission tomography (PET)Osama Sabri MD, Marwan N. Sabbagh MD, John Seibyl MD, Henryk Barthel MD,Hiroyasu Akatsu MD, Yasuomi Ouchi MD, Kohei Senda MD, Shigeo Murayama MD, Kenji Ishii MD, Masa..., Alzheimers Dement, 1/27/2015
- Phase 3 Trial of [18F]Flutemetamol Imaging and Neuritic Plaque DensityCraig Curtis , Jose Gamez , Upinder Singh , Carl Sadowsky , Teresa Villena , Marwan Sabbagh , Thomas Beach , Ranjan Duara , Adam Fleisher , Kirk Frey , Zuzana Walker ,..., JAMA Neurology, 1/26/2015
- Join now to see all
Books/Book Chapters
Press Mentions
- Quest Diagnostics Extends Alzheimer's Disease Portfolio with New AI-Powered Test Service from uMETHOD HealthMay 4th, 2023
- Pimavanserin’s Positive Impact on Mortality, Concerns over Lecanemab Patient Deaths, FDA Approves Zoom RDL Access SystemJanuary 7th, 2023
- Halting Hallucinations: A Discussion of Management Strategies for Parkinson’s Disease PsychosisJanuary 4th, 2023
- Join now to see all
Grant Support
- Study On Thalidomide As BACE1 Inhibitor In Alzhiemer'S DiseaseNational Institute On Aging2009–2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: